Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Lotte Keikes, Miriam Koopman, Martijn M. Stuiver, Valery E. P. P. Lemmens, Martijn G. H. van Oijen & Cornelis J. A. Punt. (2020) Practice variation on hospital level in the systemic treatment of metastatic colorectal cancer in The Netherlands: a population-based study. Acta Oncologica 59:4, pages 395-403.
Read now
Read now
T. Rautenberg, U. Siebert, D. Arnold, J. Bennouna, S. Kubicka, S. Walzer & C. Ngoh. (2014) Economic outcomes of sequences which include monoclonal antibodies against vascular endothelial growth factor and/or epidermal growth factor receptor for the treatment of unresectable metastatic colorectal cancer. Journal of Medical Economics 17:2, pages 99-110.
Read now
Read now
Articles from other publishers (25)
H. Jo, M.-S. Lee, Y.-P. Lee, H. Kim, J.Y. Hong, J. Lee, S.H. Park, J.O. Park, Y.S. Park, H.Y. Lim, W.K. Kang & S.T. Kim. (2022) A Comparison of Folinic Acid, Fluorouracil and Irinotecan (FOLFIRI) plus Bevacizumab and FOLFIRI plus Aflibercept as Second-line Treatment for Metastatic Colorectal Cancer. Clinical Oncology 34:8, pages e323-e328.
Crossref
Crossref
George Kafatos, Victoria Banks, Peter Burdon, David Neasham, Kimberly A Lowe, Caroline Anger, Fil Manuguid & Jörg Trojan. (2021) Impact of biomarkers and primary tumor location on the metastatic colorectal cancer first-line treatment landscape in five European countries. Future Oncology 17:12, pages 1495-1505.
Crossref
Crossref
Patricia A. H. Hamers, Marloes A. G. Elferink, Rebecca K. Stellato, Cornelis J. A. Punt, Anne M. May, Miriam Koopman & Geraldine R. Vink. (2020) Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data. International Journal of Cancer 148:2, pages 296-306.
Crossref
Crossref
Zineb Aoullay, Meriem Slaoui, Rachid Razine, Bouchra Meddah & Yahia Cherrah. (2021) Clinicopathological features of colorectal cancers in Morocco based on the registry of the National Institute of Oncology in Rabat. Annals of Cancer Research and Therapy 29:1, pages 73-78.
Crossref
Crossref
Ruihua Xu, Wei Wang, Bo Zhu, Xiaoyan Lin, Dong Ma, Lingjun Zhu, Qingchuan Zhao, Yongzhan Nie, Xiaohong Cai, Qi Li, Weijia Fang, Hongyan Li, Ning Wang, Yun Chen, Cike Peng, Honghao Fang & Lin Shen. (2020) Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China. BMC Cancer 20:1.
Crossref
Crossref
Tung Hoang & Jeongseon Kim. (2020) Combining Correlated Outcomes and Surrogate Endpoints in a Network Meta-Analysis of Colorectal Cancer Treatments. Cancers 12:9, pages 2663.
Crossref
Crossref
E. Aranda, E. Polo, C. Camps, A. Carrato, E. Díaz-Rubio, V. Guillem, R. López & A. Antón. (2020) Treatment patterns for metastatic colorectal cancer in Spain. Clinical and Translational Oncology 22:9, pages 1455-1462.
Crossref
Crossref
Rachel Delahunty, Margaret Lee, Hui‐Li Wong, Julie Johns, Joseph Mckendrick, Belinda Lee, Suzanne Kosmider, Prasad Cooray, Sumitra Ananda, Jayesh Desai, Ben Tran, Jeanne Tie, Peter Gibbs & Rachel Wong. (2020) Utilisation of systemic therapy options in routine treatment of metastatic colorectal cancer in Australia. Internal Medicine Journal 50:2, pages 165-172.
Crossref
Crossref
Alfred I. Neugut, Aijing Lin, Gabriel T. Raab, Grace Clarke Hillyer, Deborah Keller, Daniel S. O’Neil, Melissa Kate Accordino, Ravi P. Kiran, Jason Wright & Dawn L. Hershman. (2019) FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data. Clinical Colorectal Cancer 18:2, pages 133-140.
Crossref
Crossref
Ugutz Unzueta, María Virtudes Cespedes, Rita Sala, Patricia Alamo, Alejandro Sánchez-Chardi, Mireia Pesarrodona, Laura Sánchez-García, Olivia Cano-Garrido, Antonio Villaverde, Esther Vázquez, Ramón Mangues & Joaquin Seras-Franzoso. (2018) Release of targeted protein nanoparticles from functional bacterial amyloids: A death star-like approach. Journal of Controlled Release 279, pages 29-39.
Crossref
Crossref
Neal Bhutiani & Robert C. G. MartinIIII. 2018. Primary and Metastatic Liver Tumors. Primary and Metastatic Liver Tumors
217
231
.
Paolo Marchetti, Nicolai Maass, Joseph Gligorov, Karin Berger, Finlay MacDougall, Jukka Montonen & Jan Lewis. (2017) Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective. The Breast 32, pages 247-255.
Crossref
Crossref
Long Bai, Feng Wang, Zhe-zhen Li, Chao Ren, Dong-sheng Zhang, Qi Zhao, Yun-xin Lu, De-shen Wang, Huai-qiang Ju, Miao-zhen Qiu, Zhi-qiang Wang, Feng-hua Wang & Rui-hua Xu. (2016) Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer. Medicine 95:51, pages e4531.
Crossref
Crossref
Neal Bhutiani, Olaguoke Akinwande & Robert C. G. MartinIIII. (2015) Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases. World Journal of Surgery 40:5, pages 1178-1190.
Crossref
Crossref
Neal Bhutiani & Robert C.G. MartinIIII. (2016) Transarterial Therapy for Colorectal Liver Metastases. Surgical Clinics of North America 96:2, pages 369-391.
Crossref
Crossref
Long Bai, Dong-sheng Zhang, Wen-jing Wu, Chao Ren, De-shen Wang, Feng Wang, Miao-zhen Qiu & Rui-hua Xu. (2015) Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment. Medical Oncology 32:2.
Crossref
Crossref
Cristina Grávalos Castro, Ferran Pérez-Alcántara, José Antonio Gasquet Espuña & Ignasi Campos Tapias. (2013) Estudio de minimización de costes de panitumumab frente a cetuximab en combinación con quimioterapia en primera línea y segunda línea en el cáncer colorrectal metastásico KRAS nativo en España. PharmacoEconomics Spanish Research Articles 11:4, pages 135-145.
Crossref
Crossref
Pamela B. Landsman-Blumberg, Gebra Cuyun Carter, Barbara H. Johnson, Robert Sedgley, Steven J. Nicol, Li Li & Veena Shankaran. (2014) Metastatic Colorectal Cancer Treatment Patterns According to Kirsten Rat Sarcoma Viral Oncogene Homolog Genotype in U.S. Community-Based Oncology Practices. Clinical Colorectal Cancer 13:3, pages 178-184.
Crossref
Crossref
Covadonga Torres, Itziar Oyagüez, Virginia Lozano, Carles Pericay, Montserrat Pàmpols & Miguel Ángel Casado. (2013) Análisis de patrones de tratamiento y coste farmacológico en pacientes con cáncer colorrectal metastásico en un hospital general. PharmacoEconomics Spanish Research Articles 11:3, pages 85-96.
Crossref
Crossref
T. A. Abrams, G. Meyer, D. Schrag, J. A. Meyerhardt, J. Moloney & C. S. Fuchs. (2014) Chemotherapy Usage Patterns in a US-Wide Cohort of Patients With Metastatic Colorectal Cancer. JNCI Journal of the National Cancer Institute 106:2, pages djt371-djt371.
Crossref
Crossref
Bernardo Santos-Ramos, Rocío Fernández-Fernández, Roberto Marín-Gil, María Espinosa-Bosch, Salvador Peiró-Moreno, Concepción Pérez-Guerrero & Javier Bautista-Paloma. (2013) Use of monoclonal antibodies for metastatic colorectal cancer in the andalusian public health system. International Journal of Clinical Pharmacy 35:4, pages 550-553.
Crossref
Crossref
Francesco CelliniBruno Vincenzi. (2013) The variation in treating colorectal cancer between Europe and America. Colorectal Cancer 2:3, pages 177-180.
Crossref
Crossref
B. Budai, T. Nagy, I. Láng & E. Hitre. (2012) The use of high dose d,l-leucovorin in first-line bevacizumab+mFOLFIRI treatment of patients with metastatic colorectal cancer may enhance the antiangiogenic effect of bevacizumab. Angiogenesis 16:1, pages 113-121.
Crossref
Crossref
Mitch DeKoven, Vijayveer Bonthapally, Xiaolong Jiao, Arijit Ganguli, Prathamesh Pathak, Won Chan LeeSaurabh Ray. (2012) Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the UK, Germany, France, Spain and Italy (EU-5): results from a physician survey. Journal of Comparative Effectiveness Research 1:5, pages 453-463.
Crossref
Crossref
Sharon Marsh. (2012) Research Highlights: Highlights from the latest articles in colorectal cancer pharmacogenomics. Pharmacogenomics 13:7, pages 743-746.
Crossref
Crossref